Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NETILMICIN: 64 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
64
Total FAERS Reports
24 (37.5%)
Deaths Reported
29
Hospitalizations
64
As Primary/Secondary Suspect
15
Life-Threatening
1
Disabilities
Feb 28, 1983
FDA Approved
Discontinued
Status

FDA Application: 050544 ·

First Report: 2009 · Latest Report: 20200301

What Are the Most Common NETILMICIN Side Effects?

#1 Most Reported
Pyrexia
20 reports (31.3%)
#2 Most Reported
Off label use
19 reports (29.7%)
#3 Most Reported
Stevens-johnson syndrome
13 reports (20.3%)

All NETILMICIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Pyrexia 20 31.3% 13 2
Off label use 19 29.7% 17 6
Neutropenia 13 20.3% 13 0
Renal impairment 13 20.3% 13 0
Skin disorder 13 20.3% 13 0
Skin exfoliation 13 20.3% 13 0
Stevens-johnson syndrome 13 20.3% 0 2
Drug ineffective 11 17.2% 8 7
Mucormycosis 11 17.2% 11 0
Drug ineffective for unapproved indication 9 14.1% 9 0
Shock 9 14.1% 8 1
C-reactive protein increased 8 12.5% 8 0
Disseminated mucormycosis 8 12.5% 8 0
Fungal sepsis 8 12.5% 8 0
Adverse event 5 7.8% 0 5
Asthma 5 7.8% 0 5
Blood test abnormal 5 7.8% 0 5
Burning sensation 5 7.8% 0 5
Cardiac disorder 5 7.8% 0 5
Carpal tunnel syndrome 5 7.8% 0 5

Who Reports NETILMICIN Side Effects? Age & Gender Data

Gender: 45.5% female, 54.5% male. Average age: 25.4 years. Most reports from: FI. View detailed demographics →

Is NETILMICIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2009 1 0 1
2010 1 0 1
2015 2 0 2
2016 11 0 0
2019 2 0 0
2020 2 0 2

View full timeline →

What Is NETILMICIN Used For?

IndicationReports
Product used for unknown indication 18
Ophthalmic herpes zoster 15

Official FDA Label for NETILMICIN

Official prescribing information from the FDA-approved drug label.